5 Red Flags in Peptide Marketing — How to Spot Them
Not all peptide providers are equal. Here are five warning signs that should make you think twice before handing over your health — or your money.
The Australian peptide market is growing fast. So is the number of providers operating in it — with very different standards. Knowing how to evaluate what you're looking at is genuinely useful.
1. No Prescription Required
Therapeutic peptides in Australia are Schedule 4 prescription medicines. If a provider is selling or facilitating access to peptides without a prescription from an AHPRA-registered doctor, they're operating outside the law. A legitimate provider will always require a clinical consultation and a valid prescription. If that step is missing or optional, walk away.
2. 'For Research Use Only'
The TGA has been explicit: labelling a product 'for research use only' doesn't change its regulatory status if it's being supplied for human therapeutic use. Beyond the legal issue, research-grade peptides are not manufactured to pharmaceutical standards.
3. Guaranteed or Dramatic Outcome Claims
Legitimate medical practice doesn't guarantee outcomes. When a peptide provider makes specific guarantees — 'lose 10kg in 8 weeks,' 'fully healed tendons,' 'look 10 years younger' — that's a signal that marketing has overtaken clinical honesty.
4. No Identifiable Doctor
Legitimate programs involve a real, identifiable, AHPRA-registered doctor who is personally responsible for your clinical assessment. You can verify any practitioner's registration at ahpra.gov.au.
5. Testimonials About Clinical Outcomes
AHPRA regulations prohibit the use of patient testimonials that reference clinical outcomes in healthcare advertising. If a peptide clinic prominently features patient testimonials about their results, they're in breach of AHPRA's advertising guidelines.
MEORA is built around clinical integrity. AHPRA-registered doctors, TGA-licensed pharmacy, no outcome guarantees. Learn how it works →
